Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cell Signal. 2012 Jul 20;24(12):2291–2296. doi: 10.1016/j.cellsig.2012.07.009

Fig. 6.

Fig. 6

Silibinin inhibited prostate and breast cancer cell proliferation. Prostate cancer PC-3 and DU145 cells and breast cancer MDA-MB-231 and T-47D cells in 96-well plates were treated with silibinin for 72 h. Cell viability was measured by the Cell Titer Glo Assay system. All the values are the average of triplicate determinations.